Successful Use of Bortezomib for Recurrent Progressive Familial Intrahepatic Cholestasis Type II After Liver Transplantation: A Pediatric Case with a 9-Year Follow-Up

키워드

참고문헌 (20)

1. Strautnieks SS, "Severe bile salt export pump deficiency : 82 different ABCB11 mutations in 109 families", Gastroenterology, 134, pp.1203~1214 (2008)
2. Davit-Spraul A, "ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis(PFIC) : phenotypic differences between PFIC1 and PFIC2 and natural history", Hepatology, 51, pp.1645~1655 (2010)
3. Baker A, "Systematic review of progressive familial intrahepatic cholestasis", Clin Res Hepatol Gastroenterol, 43, pp.20~36 (2019)
4. Thompson RJ, "Odevixibat treatment in progressive familial intrahepatic cholestasis : a randomised, placebo-controlled, phase 3 trial", Lancet Gastroenterol Hepatol, 7, pp.830~842 (2022)
5. Oh SH, "Recent improvement in survival outcomes and reappraisal of prognostic factors in pediatric living donor liver transplantation", Liver Transpl, 28, pp.1011~1023 (2022)
6. Jara P, "Recurrence of bile salt export pump deficiency after liver transplantation", N Engl J Med, 361, pp.1359~1367 (2009)
7. Lin HC, "Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation", Liver Transpl, 19, pp.1403~1410 (2013)
8. Field-Smith A, "Bortezomib(Velcadetrade mark)in the treatment of multiple myeloma", Ther Clin Risk Manag, 2, pp.271~279 (2006)
9. Neubert K, "The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis", Nat Med, 14, pp.748~755 (2008)
10. Paterno F, "Bortezomib for acute antibody-mediated rejection in liver transplantation", Am J Transplant, 12, pp.2526~2531 (2012)
11. Shah N, "Bortezomib in kidney transplantation", Curr Opin Organ Transplant, 20, pp.652~656 (2015)
12. Smith MR, "Rituximab(monoclonal anti-CD20 antibody) : mechanisms of action and resistance", Oncogene, 22, pp.7359~7368 (2003)
13. Baradaran H, "Antibody-mediated rejection in adult liver transplant recipients : a case series and literature review", J Clin Pharmacol, 62, pp.254~271 (2022)
14. Keitel V, "De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation : a novel mechanism of cholestasis", Hepatology, 50, pp.510~517 (2009)
15. Kubitz R, "Autoimmune BSEP disease : disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis", Clin Rev Allergy Immunol, 48, pp.273~284 (2015)
16. Quintero J, "Successful treatment with rituximab and immunoadsorption for an auto-antibody induced bile salt export pump deficiency in a liver transplanted patient", Pediatr Gastroenterol Hepatol Nutr, 23, pp.174~179 (2020)
17. Chedid MF, "Bortezomib : a new promising therapy for early antibody-mediated rejection after liver transplantation?", Transplant Direct, 5, pp.e492~ (2019)
18. Lee CF, "Bortezomib is effective to treat acute humoral rejection after liver transplantation", Transplant Proc, 44, pp.529~531 (2012)
19. Everly MJ, "Proteasome inhibition reduces donor-specific antibody levels", Transplant Proc, 41, pp.105~107 (2009)
20. Lee WC, "Clinical relevance of isoagglutinin rebound in adult ABO-incompatible living donor liver transplantation", J Pers Med, 11, pp.1300~ (2021)

관련 논문AI추천